Veradermics/$MANE
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Veradermics
Veradermics Inc clinical-stage biopharmaceutical company focused on developing therapeutics to address pervasive treatment challenges in prevalent aesthetic and dermatological conditions. The company operates in a single segment of allocating resources, assessing performance, and making operating decisions.
Ticker
$MANE
Sector
Primary listing
NYSE
Employees
19
Headquarters
Website
Veradermics Metrics
BasicAdvanced
$2.8B
-
-$93.95
-
-
Price and volume
Market cap
$2.8B
52-week high
$80.90
52-week low
$32.00
Average daily volume
476K
Financial strength
Current ratio
16.662
Quick ratio
15.638
Long term debt to equity
0.003
Total debt to equity
0.003
Profitability
Management effectiveness
Return on assets (TTM)
-43.45%
Return on equity (TTM)
-72.06%
Valuation
Price to book
-0.45
Price to tangible book (TTM)
-0.45
Price to free cash flow (TTM)
-0.771
Free cash flow yield (TTM)
-129.71%
Free cash flow per share (TTM)
-96.143
Growth
Earnings per share change (TTM)
153.59%
What the Analysts think about Veradermics
Analyst ratings (Buy, Hold, Sell) for Veradermics stock.
Veradermics Financial Performance
Revenues and expenses
Veradermics Earnings Performance
Company profitability
Veradermics News
AllArticlesVideos
Veradermics Reports Fourth Quarter and Full Year 2025 Financial Results and Highlights Recent Corporate and Clinical Updates
Business Wire·3 weeks ago
Veradermics Announces Presentations on VDPHL01 and Patient Experiences With Pattern Hair Loss at 2026 American Academy of Dermatology Annual Meeting
Business Wire·4 weeks ago
Veradermics to Participate in Upcoming March Investor Conferences
Business Wire·1 month ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Veradermics stock?
Veradermics (MANE) has a market cap of $2.8B as of April 17, 2026.
What is the P/E ratio for Veradermics stock?
The price to earnings (P/E) ratio for Veradermics (MANE) stock is 0 as of April 17, 2026.
Does Veradermics stock pay dividends?
No, Veradermics (MANE) stock does not pay dividends to its shareholders as of April 17, 2026.
When is the next Veradermics dividend payment date?
Veradermics (MANE) stock does not pay dividends to its shareholders.
What is the beta indicator for Veradermics?
Veradermics (MANE) does not currently have a Beta indicator.